Personal injury in
Philadelphia.
Philadelphia personal injury settlements are shaped by reliably plaintiff-friendly Common Pleas juries and the Complex Litigation Center's dominance in pharmaceutical and medical-device mass torts.
Philadelphia County Court of Common Pleas is one of the most consequential personal-injury venues in the United States — not for routine auto cases (which are throttled by Pennsylvania's "limited tort" insurance option) but for pharmaceutical and medical-device mass-tort filings concentrated in the court's Complex Litigation Center. Plaintiff verdicts in CLC programs (Risperdal, Xarelto, talc, hernia mesh, others) have repeatedly produced nine-figure awards.
Pennsylvania operates modified-comparative fault with a 51% bar (42 Pa. C.S. § 7102) and a 2-year limitation on negligence claims (§ 5524). The "limited tort" election under 75 Pa. C.S. § 1705 — chosen by most PA drivers in exchange for lower auto premiums — substantially restricts non-economic recovery in auto cases unless the injury meets the "serious injury" threshold.
SEPTA and other public-transit claims are subject to the political-subdivision damages cap of $500,000 per claimant under 42 Pa. C.S. § 8553, a meaningful constraint on transit-injury recovery.